Global Patent Index - EP 1569645 A2

EP 1569645 A2 20050907 - METHOD OF USING AMINOCYANOPYRIDINE COMPOUNDS AS MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS

Title (en)

METHOD OF USING AMINOCYANOPYRIDINE COMPOUNDS AS MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS

Title (de)

VERFAHREN ZUR VERWENDUNG VON AMINOCYANOPYRIDIN-VERBINDUNGEN ALS MITOGENAKTIVIERTE PROTEINKINASE-AKTIVIERTE PROTEINKINASE-2-HEMMER

Title (fr)

PROCEDE D'UTILISATION DE COMPOSES D'AMINOCYANOPYRIDINE EN TANT QU'INHIBITEURS DE LA PROTEINE MAPKAP KINASE-2

Publication

EP 1569645 A2 20050907 (EN)

Application

EP 03813364 A 20031209

Priority

  • US 0339166 W 20031209
  • US 43280702 P 20021212

Abstract (en)

[origin: WO2004054505A2] A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject an anminocyanopyridine MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.

IPC 1-7

A61K 31/44

IPC 8 full level

A61K 31/4162 (2006.01); A61K 31/4164 (2006.01); A61K 31/4188 (2006.01); A61K 31/44 (2006.01); A61K 31/455 (2006.01); A61K 31/473 (2006.01); A61K 31/4745 (2006.01); C07D 491/052 (2006.01); C07D 491/153 (2006.01); C07D 507/00 (2006.01)

CPC (source: EP)

A61K 31/4162 (2013.01); A61K 31/4164 (2013.01); A61K 31/4188 (2013.01); A61K 31/44 (2013.01); A61K 31/455 (2013.01); A61K 31/473 (2013.01); A61K 31/4745 (2013.01); A61P 1/00 (2017.12); A61P 1/02 (2017.12); A61P 1/04 (2017.12); A61P 3/10 (2017.12); A61P 7/06 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 15/02 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/04 (2017.12); A61P 19/06 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/04 (2017.12); A61P 25/06 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 31/22 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 43/00 (2017.12)

Citation (search report)

See references of WO 2004054505A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2004054505 A2 20040701; WO 2004054505 A3 20040902; AU 2003296414 A1 20040709; AU 2003296414 A8 20040709; BR 0317183 A 20051101; CA 2508780 A1 20040701; EP 1569645 A2 20050907; JP 2006512338 A 20060413; MX PA05006367 A 20050829

DOCDB simple family (application)

US 0339166 W 20031209; AU 2003296414 A 20031209; BR 0317183 A 20031209; CA 2508780 A 20031209; EP 03813364 A 20031209; JP 2004560746 A 20031209; MX PA05006367 A 20031209